XENE

XENE

USD

Xenon Pharmaceuticals Inc. Common Shares

$39.090-0.650 (-1.636%)

リアルタイム価格

Healthcare
バイオテクノロジー
カナダ

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$39.740

高値

$40.450

安値

$37.625

出来高

0.18M

企業ファンダメンタルズ

時価総額

3.0B

業種

バイオテクノロジー

Canada

取引統計

平均出来高

0.79M

取引所

NGM

通貨

USD

52週レンジ

安値 $26.74現在値 $39.090高値 $46

関連ニュース

Analyst Upgrades

RBC Capital Maintains Outperform on Xenon Pharmaceuticals, Raises Price Target to $58

RBC Capital analyst Brian Abrahams maintains Xenon Pharmaceuticals with a Outperform and raises the price target from $55 to $58.

もっと見る
RBC Capital Maintains Outperform on Xenon Pharmaceuticals, Raises Price Target to $58
Analyst Upgrades

Wells Fargo Maintains Overweight on Xenon Pharmaceuticals, Lowers Price Target to $44

Wells Fargo analyst Benjamin Burnett maintains Xenon Pharmaceuticals with a Overweight and lowers the price target from $48 to $44.

もっと見る
Wells Fargo Maintains Overweight on Xenon Pharmaceuticals, Lowers Price Target to $44
Analyst Upgrades

Needham Reiterates Buy on Xenon Pharmaceuticals, Maintains $55 Price Target

Needham analyst Serge Belanger reiterates Xenon Pharmaceuticals with a Buy and maintains $55 price target.

もっと見る
Needham Reiterates Buy on Xenon Pharmaceuticals, Maintains $55 Price Target
GlobeNewswire

Xenon to Report Q3 2025 Financial Results on November 3, 2025

VANCOUVER, British Columbia and BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and

もっと見る
Xenon to Report Q3 2025 Financial Results on November 3, 2025